Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert, Olaf H. Klungel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)835-843
JournalPharmacoepidemiology and Drug Safety
Issue number8
Publication statusPublished - Aug 2012


  • angiotensin-converting enzyme inhibitor
  • angiotensin II receptor blocker
  • rheumatoid arthritis
  • autoimmune
  • immunomodulation
  • case-control study
  • pharmacoepidemiology

Cite this